GL1X · GenesisL1 explorer

UniProt A0A0J9X1X7

Enoyl-[acyl-carrier-protein] reductase [NADPH] (A0A0J9X1X7)

Enoyl-[acyl-carrier-protein] reductase [NADPH] (UniProt A0A0J9X1X7), EC 1.3.1.39: 6 experimental structures on GenesisL1, 5 ligands bound, 60 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
A0A0J9X1X7
Protein
Enoyl-[acyl-carrier-protein] reductase [NADPH]
EC
1.3.1.39
Experimental structures
6
Predicted models
0
Ligands
5
Pockets
60 · 3 records with a druggable one

Structures

6 records of A0A0J9X1X7 in the MolNFT archive: 6 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
6TBBCrystal structure of S. aureus FabI in complex with NADPH and kalimantacin A (batumin)x-ray diffractionA, B, C, D, E, F, G, HNDP, KAL20 (best 0.85)
6TBBCrystal structure of S. aureus fabi in complex with NADPH and kalimantacin a (batumin)x-ray diffractionA, B, C, D, E, F, G, HNDP, KAL—
6TBCCrystal structure of S. aureus FabI in complex with NADPH and kalimantacin Bx-ray diffractionA, B, C, D, E, F, G, HNDP, N5H20 (best 0.85)
6TBCCrystal structure of S. aureus fabi in complex with NADPH and kalimantacin Bx-ray diffractionA, B, C, D, E, F, G, HNDP, N5H—
6YURCrystal structure of S. aureus FabI inhibited by SKTS1x-ray diffractionA, B, C, D, E, F, G, HNAP, F9T20 (best 0.89)
6YURCrystal structure of S. aureus fabi inhibited by SKTS1x-ray diffractionA, B, C, D, E, F, G, HNAP, F9T—

Ligands

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · in 4 records
  • F9T · 6-[4-(4-hexyl-2-oxidanyl-phenoxy)phenoxy]pyridin-2-ol · in 2 records
  • KAL · Kalimantacin · in 2 records
  • N5H · (2~{E},5~{R},10~{E},12~{E},15~{S},19~{R})-20-[[(2~{R}, 3~{R})-3-aminocarbonyloxy-2-methyl-butanoyl]amino]-3, 5,15-trimethyl-7-methylidene-19-oxidanyl-17-oxidanylidene-icosa-2,10,12-trienoic acid · in 2 records
  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · in 2 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.